Sunovion Pharmaceuticals

Sunovion Pharmaceuticals, formerly known as Sepracor, is a global biopharmaceutical company focused on the application of science and medicine to help people with serious medical conditions. The Company supports people with psychiatric, neurological, and respiratory conditions. The company discovers, develops, and commercializes such therapies as Brovana (arformoterol tartrate), Latuda (lurasidone HCI), and Aptiom (eslicarbazepine acetate).

Employee Rating

3.4
TypeSubsidiary
HQMarlborough, MA, US
Founded1984
Websitesunovion.com
Cybersecurity ratingBMore
Sunovion Pharmaceuticals was founded in 1984 and is headquartered in Marlborough, MA, US

Viewing summary data as a guest

Sign up for free to see all data
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Sunovion Pharmaceuticals

Antony Loebel

Antony Loebel

President and Chief Executive Officer
Greg Bokar

Greg Bokar

Executive Vice President, General Counsel and Corporate Secretary
Linda Arsenault

Linda Arsenault

Senior Vice President, Chief Human Resources Officer
Stephen Freeman

Stephen Freeman

Executive Vice President, Chief Financial Officer
Thomas Gibbs

Thomas Gibbs

Senior Vice President, Chief Commercial Officer
Susan Kalk

Susan Kalk

Senior Vice President, Chief Quality & Technical Operations Officer
Show more

Sunovion Pharmaceuticals Office Locations

Sunovion Pharmaceuticals has offices in Marlborough, Fort Lee, Mississauga and London
Marlborough, MA, US (HQ)
84 Waterford Dr, Marlborough
Fort Lee, NJ, US
1 Bridge Plaza N #510
Mississauga, CA
100 6790 Century Ave
Mississauga, CA
7025 Langer Dr #301
London, GB
105 Victoria St, Westminster
Show all (5)

Sunovion Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

1984

Investors

Sunovion Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Sunovion Pharmaceuticals Online and Social Media Presence

Embed Graph

Sunovion Pharmaceuticals Company Culture

  • Overall Culture

    B

    71/100

  • CEO Rating

    D

    60/100

  • Compensation

    C+

    67/100

Learn more on Comparably

Sunovion Pharmaceuticals Blogs

Sunovion Announces FDA Filing Acceptance of Resubmitted New Drug Application for Apomorphine Sublingual Film

Dateline City: MARLBOROUGH, Mass. MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for apomorphine…

Sunovion Announces Results from Its Open-Label Extension Study of SEP-363856 in Schizophrenia

Dateline City: MARLBOROUGH, Mass. — SEP-363856 was generally safe and well tolerated throughout the six-month study — — Treatment with SEP-363856 was associated with clinically meaningful improv…

Actor and Advocate Chyler Leigh and the American Foundation for Suicide Prevention Join Be Vocal: Speak Up for Mental Health Initiative

Dateline City: MARLBOROUGH, Mass. Leigh is speaking up for the first time about living with bipolar disorder to encourage people to seek help and advocate for their mental health Be Vocal launch…

Sunovion Resubmits New Drug Application for Apomorphine Sublingual Film

Dateline City: MARLBOROUGH, Mass. MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced the resubmission of the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for apomor…

Sunovion President and CEO Dr. Antony Loebel Receives Outstanding Leadership Award at CNS Summit

Dateline City: MARLBOROUGH, Mass. MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Antony Loebel, M.D., President and Chief Executive Officer of Sunovion, received the Leadership Award d…

Sunovion Answers Becomes a J.D. Power 2019 Certified Customer Service Program℠

Dateline City: MARLBOROUGH, Mass. – Sunovion’s support services program is recognized by J.D. Power for providing an outstanding customer service experience – MARLBOROUGH, Mass…
Show more

Sunovion Pharmaceuticals Frequently Asked Questions

  • When was Sunovion Pharmaceuticals founded?

    Sunovion Pharmaceuticals was founded in 1984.

  • Who are Sunovion Pharmaceuticals key executives?

    Sunovion Pharmaceuticals's key executives are Antony Loebel, Greg Bokar and Linda Arsenault.

  • How many employees does Sunovion Pharmaceuticals have?

    Sunovion Pharmaceuticals has 2,077 employees.

  • Who are Sunovion Pharmaceuticals competitors?

    Competitors of Sunovion Pharmaceuticals include Livzon Pharmaceutical Group, PPD and Alembic Pharmaceuticals.

  • Where is Sunovion Pharmaceuticals headquarters?

    Sunovion Pharmaceuticals headquarters is located at 84 Waterford Dr, Marlborough, Marlborough.

  • Where are Sunovion Pharmaceuticals offices?

    Sunovion Pharmaceuticals has offices in Marlborough, Fort Lee, Mississauga and London.

  • How many offices does Sunovion Pharmaceuticals have?

    Sunovion Pharmaceuticals has 5 offices.